Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy.

Yin, Xiaoran; Feng, Yan; Zhang, Bowen; Mao, Xueyan; Chen, Siying; Wang, Yuyan; Fu, Sidney W

Yin, Xiaoran; Feng, Yan; Zhang, Bowen; Mao, Xueyan; Chen, Siying; Wang, Yuyan; Fu, Sidney W.

Afiliação

Yin X; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Feng Y; Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhang B; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Mao X; Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen S; Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Fu SW; Division of Cancer Prevention (Cancer Biomarkers Research Group), National Cancer Institute, Rockville, MD, United States.

Front Oncol ; 13: 1301340, 2023.

Article em En | MEDLINE | ID: mdl-38023135